ResearchMoz

Telehealth and Telemedicine - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

GlobalData
Published Date » 2012-08-07
No. Of Pages » 60


GlobalDatas new report, Telehealth and Telemedicine - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global sports medicine implants market. The report provides market landscape, competitive landscape and market trends information on the telehealth and telemedicine market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope


  • Key geographies covered include the US, Europe and Asia Pacific. 
  • Key segments covered include telehealth and telemedicine and mobile health.
  • Annualized market revenues data from forecast forward for seven years to 2018.
  • Qualitative analysis of key market trends, market drivers, and restraints within the telehealth and telemedicine market. 
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
  • Key players covered include Philips Healthcare, AMD Global Telemedicine, Intel GE Innovations, Aerotel Medical Systems, Honeywell, AT&T, Cisco, Verizon Business, Polycom, Sony Corporation and Robert Bosch Healthcare.
Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the telehealth and telemedicine market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • Whats the next big thing in the telehealth and telemedicine market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global sports medicine implants market and the factors shaping it.
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5

2 Introduction 6
2.1 GlobalData Report Guidance 6

3 Telehealth and Telemedicine - Overview 7
3.1 Introduction 7
3.2 Types of Telemedicine Solutions and Services 8
3.2.1 Synchronous Telemedicine Solutions 8
3.2.2 Asynchronous Telemedicine Solutions 9
3.3 Types of Non-clinical Telehealth Solutions/Services 10
3.3.1 Personal Health Records 10
3.3.2 Mobile Health Applications 10
3.3.3 Medical Education Services 10

4 Telehealth and Telemedicine - Market Characterization 11
4.1 Telehealth and Telemedicine Market, Global, Revenue ($bn), Forecast, 20112018 11
4.2 Telehealth and Telemedicine, Market Dynamics 12
4.2.1 Market Drivers 12
4.2.2 Market Restraints 19

5 Global Telehealth and Telemedicine Market - mHealth Market 23
5.1 mHealth Market, Global, Revenue ($bn), 20112018 23
5.2 mHealth Market, Global, Revenue Share, by Segment, 2011 24
5.3 mHealth Market, Global, Revenue Share, by Geography, 2011 25
5.4 mHealth Market, Global, Revenue ($bn), by Payer, 2011 26

6 Global Telehealth and Telemedicine Market - Geography Analysis and Forecast 27

6.1 The US Telehealth and Telemedicine Market, Revenues ($bn), 20112018 27
6.2 The US Telehealth and Telemedicine Market, Revenues (% Share), by Location, 2011 29
6.3 Europe Telehealth and Telemedicine Market, Revenues ($bn), 20112018 30
6.4 Europe Telehealth and Telemedicine Market, Revenue (% Share), by Location, 2011 31
6.5 Asia-Pacific Telehealth and Telemedicine Market, Revenue ($m), 20112018 32
6.6 Asia-Pacific Telehealth and Telemedicine Market, Revenue (% Share), by Location, 2011 33

7 Telehealth and Telemedicine Market - Strategic Competitive Assessment 34
7.1 Telehealth and Telemedicine Market: Strategic Assessment by Disease 34
7.2 Telehealth and Telemedicine Market: Strategic Assessment by Treatment Type 35
7.3 Telehealth and Telemedicine Market: Key Healthcare Providers 36
7.3.1 Philips Healthcare 36
7.3.2 AMD Global Telemedicine 37
7.3.3 Intel-GE Care Innovations 38
7.3.4 Aerotel Medical Systems 39
7.3.5 Honeywell HomMed 40
7.4 Telehealth and Telemedicine Market: Key Telecom Players 41
7.4.1 AT&T 41
7.4.2 Cisco 42
7.4.3 Verizon Business 43
7.5 Telehealth and Telemedicine Market: Key Technology Players 44
7.5.1 Polycom 44
7.5.2 Sony Corporation 45
7.5.3 Robert Bosch Healthcare 46
7.6 Key Mobile App Vendors 47

8 Telehealth and Telemedicine Market - M&A Landscape 49
8.1 Telehealth and Telemedicine Market: Deal Overview 49
8.2 Key Partnerships (20092012) 49
8.2.1 Robert Bosch Enters into Licensing Agreement with Waldo Networks for Telehealth Patent Portfolio (April 24, 2012) 49
8.2.2 Philips Healthcare and Vidyo Collaborate for Enterprise-wide Deployment of Next-generation Telehealth Services (April 24, 2012) 50
8.2.3 Cisco Systems Enters into an Agreement with GE HealthCare (February 22, 2011) 51
8.2.4 GE Healthcare Forms Joint Venture with Intel (January 3, 2011) 51
8.2.5 Ideal Life Partners with Shandong Novatech Biopharmaceutical (November 26, 2010) 52
8.3 Key Acquisitions (20092012) 52
8.3.1 Tunstall Healthcare Completes Acquisition of STT Condigi (March 1, 2012) 52
8.3.2 Aetna Acquires Healthagen (December 20, 2011) 53
8.3.3 Siemens Healthcare to Acquire MobileMD (November 4, 2011) 53
8.3.4 iMD Companies Acquires Optimum Mobile Imaging (April 21, 2011) 53
8.3.5 GE Healthcare Acquires Living Independently Group (December 1, 2009) 54
8.3.6 Bosch Acquires ViTel Net (April 10, 2009) 54

9 Appendix 55
9.1 Definitions 56
9.1.1 Telemedicine/Telehealth 56
9.2 Abbreviations 57
9.3 Sources 58
9.4 Research Methodology 58
9.4.1 Secondary Research 58
9.4.2 Primary Research 59
9.4.3 Models 59
9.4.4 Forecasts 59
9.4.5 Expert Panels 60
9.4.6 GlobalData Consulting 60
9.5 Contact Us 60
9.6 Disclaimer 60

List of Tables


Table 1: Roles and Benefits of Remote Patient Monitoring Technologies in Chronic Disease Management 9
Table 2: Telehealth and Telemedicine Market, Global, Revenue ($bn), 20112018 11
Table 3: Subscriber Base by ICT Type, Global, 20062011 15
Table 4: Growth Potential of Healthcare IT Markets, Revenue ($bn), 20042018 17
Table 5: Venture Capital Investments in Mobile Health, Net Value ($m), 20102011 18
Table 6: Examples of Key Deals in Telehealth and Telemedicine Market, 2012 19
Table 7: ICT Penetration Indicators, Developed vs. Developing Countries, Number of Subscribers Per 100 Inhabitants, 2011* 21
Table 8: mHealth Market, Global, Revenue ($bn), 20112018 23
Table 9: mHealth Market, Global, Revenue ($bn), by Segment, 2011 24
Table 10: mHealth Market, Global, Revenue ($bn), by Geography, 2011 25
Table 11: mHealth Market, Global, Revenue ($bn), by Payer, 2011 26
Table 12: Telehealth and Telemedicine Market, The US, Revenue ($bn), 20112018 27
Table 13: Telehealth and Telemedicine Market, Europe, Revenue ($bn), 20112018 30
Table 14: Telehealth and Telemedicine Market, Asia-Pacific, Revenue ($m), 20112018 32
Table 15: Key Telehealth and Telemedicine Portfolio, Philips Healthcare, 2012 36
Table 16: Key Telehealth and Telemedicine Portfolio, AMD Global Telemedicine, 2012 37
Table 17: Key Telehealth and Telemedicine Portfolio, Intel-GE Care Innovations, 2012 38
Table 18: Key Telehealth and Telemedicine Portfolio, Aerotel Medical Systems, 2012 39
Table 19: Key Telehealth and Telemedicine Portfolio, Honeywell HomMed, 2012 40
Table 20: Key Telehealth and Telemedicine Portfolio, AT&T, 2012 41
Table 21: Key Telehealth and Telemedicine Portfolio, Cisco Systems, 2012 42
Table 22: Key Telehealth and Telemedicine Portfolio, Verizon Business, 2012 43
Table 23: Key Telehealth and Telemedicine Portfolio, Polycom, 2012 44
Table 24: Key Telehealth and Telemedicine Portfolio, Sony Corporation, 2012 45
Table 25: Key Telehealth and Telemedicine Portfolio, Robert Bosch Healthcare, 2012 46
Table 26: Number of Health Applications, by Vendor Store, 2010 47
Table 27: Top Health Apps, Apple App Store, 2011 48

List of Figures


Figure 1: Telehealth and Telemedicine, Market Segmentation 7
Figure 2: Overview of Patient Workflow in a Remote Patient Monitoring Setup 8
Figure 3: Telehealth and Telemedicine Market, Global, Revenue ($bn), 20112018 11
Figure 4: Telehealth and Telemedicine, Market Dynamics 12
Figure 5: Key Government Initiatives for Telehealth, by Country, 20092016 14
Figure 6: Subscriber Base by ICT Type, Global, 20062011 15
Figure 7: Growth Potential of Healthcare IT Markets, Revenue ($bn), 20042018 17
Figure 8: Venture Capital Investments in Mobile Health, Net Value ($m), 20102011 18
Figure 9: Key Barriers to Mobile Technology in Healthcare, 2011 20
Figure 10: ICT Penetration Indicators, Developed vs. Developing Countries, 2011* 21
Figure 11: mHealth Market, Global, Revenue ($bn), 20112018 23
Figure 12: mHealth Market, Global, Revenue (% Share), by Segment, 2011 24
Figure 13: mHealth Market, Global, Revenue (% Share), by Geography, 2011 25
Figure 14: mHealth Market, Global, Revenue (% share), by Payer, 2011 26
Figure 15: Telehealth and Telemedicine Market, The US, Revenue ($bn), 20112018 27
Figure 16: The US Telehealth and Telemedicine Market, Revenues (% Share), by Location, 2011 29
Figure 17: Telehealth and Telemedicine Market, Europe, Revenue ($bn), 20112018 30
Figure 18: Europe Telehealth and Telemedicine Market, Revenue (% Share), by Location, 2011 31
Figure 19: Telehealth and Telemedicine Market, Asia-Pacific, Revenue ($m), 20112018 32
Figure 20: Asia-Pacific Telehealth and Telemedicine Market, Revenue (% Share), by Location, 2011 33
Figure 21: Telehealth and Telemedicine Market: Strategic Assessment by Disease 34
Figure 22: Telehealth and Telemedicine Market: Strategic Assessment by Treatment Type 35
Figure 23: Number of Health Applications, by Vendor Store, 2010 47

Upcoming Reports:

Autologous Cell Therapy Market - Global Forecast, Market Share, Size, Growth and Industry Analysis, 2011-2018
By - Transparency Market Research
Autologous cell therapy is a therapeutic procedure which uses the cells of an individual, which are well-bred and nurtured outside the body and then reintroduced at the site of the disease of the individual. Autologous cell therapy is a new breakthrough in the field of medical history. Autologous cell therapy (ACT) is one of the most rapidly evolving fields due to the revolution in the bioengineering sector since the last few decades.  Previously diseases like Alzheimer’s, Parkinson's were thought to be incurable; however the invention of Autologous cell therapy...
Toluene Market - Global Forecast, Market Share, Trends, Size, Growth and Industry Analysis, 2012 - 2018
By - Transparency Market Research
Toluene is a colorless, water insoluble, volatile, inflammable liquid with odor that resembles paint thinner. It is primarily obtained from petroleum and coal tar. Toluene is commonly used as industrial feedstock and as solvent. It is used in paints, inks, adhesives, disinfectants etc. It is also used as a raw material to manufacture benzene, xylene, TNT, production of pharmaceuticals, dyes and cosmetic nail products.  Toluene is often mixed with gasoline as it improves its octane number. In 2010 almost 85% of the toluene produced globally was used as solvents and...
Emulsifiers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Emulsification is a process of mixing two or more immiscible liquids with the help of an emulsifier, which is also known as an emulsifying agent. Emulsifiers help to stabilize the mixture by reducing the surface tension of the emulsion. They have major applications in food, in making of many products like ice-creams, biscuits, cake, bread, caramel, and others. In addition to this, emulsifiers are also used in detergents, medicines, and fire extinguishers. Emulsifiers are commonly used in hair styling products and cosmetics. These agents can be majorly classified into natural,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...